TY - JOUR AU - Ryan, D. P. AU - Hong, T. S. AU - Bardeesy, N. PY - 2014 DA - 2014// TI - Pancreatic Adenocarcinoma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMra1404198 DO - 10.1056/NEJMra1404198 ID - Ryan2014 ER - TY - JOUR AU - Malvezzi, M. AU - Bertuccio, P. AU - Levi, F. AU - La Vecchia, C. AU - Negri, E. PY - 2013 DA - 2013// TI - European cancer mortality predictions for the year 2013 JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt010 DO - 10.1093/annonc/mdt010 ID - Malvezzi2013 ER - TY - STD TI - Cancer Facts and Figures | American Cancer Society. 2015. http://old.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf. UR - http://old.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf ID - ref3 ER - TY - STD TI - Stewart BW, Wild CP. World Cancer Report. 2014. ISBN: 978-92-832-0443-5. ID - ref4 ER - TY - JOUR AU - Burris, H. A. AU - Moore, M. J. AU - Andersen, J. AU - Green, M. R. AU - Rothenberg, M. L. AU - Modiano, M. R. PY - 1997 DA - 1997// TI - Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial JO - J Clin Oncol VL - 15 UR - https://doi.org/10.1200/JCO.1997.15.6.2403 DO - 10.1200/JCO.1997.15.6.2403 ID - Burris1997 ER - TY - JOUR AU - Ueno, H. AU - Ioka, T. AU - Ikeda, M. AU - Ohkawa, S. AU - Yanagimoto, H. AU - Boku, N. PY - 2013 DA - 2013// TI - Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.43.3680 DO - 10.1200/JCO.2012.43.3680 ID - Ueno2013 ER - TY - JOUR AU - Conroy, T. AU - Desseigne, F. AU - Ychou, M. AU - Bouché, O. AU - Guimbaud, R. AU - Bécouarn, Y. PY - 2011 DA - 2011// TI - FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1011923 DO - 10.1056/NEJMoa1011923 ID - Conroy2011 ER - TY - JOUR AU - Von Hoff, D. D. AU - Ervin, T. AU - Arena, F. P. AU - Chiorean, E. G. AU - Infante, J. AU - Moore, M. PY - 2013 DA - 2013// TI - Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1304369 DO - 10.1056/NEJMoa1304369 ID - Von Hoff2013 ER - TY - STD TI - Jurewitsch B, Lee T, Park J, Jeejeebhoy K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr. 1998;22:242–4. ID - ref9 ER - TY - JOUR AU - Jacobi, C. A. AU - Ordemann, J. AU - Böhm, B. AU - Zieren, H. U. AU - Sabat, R. AU - Müller, J. M. PY - 1997 DA - 1997// TI - Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model JO - Am J Surg VL - 174 UR - https://doi.org/10.1016/S0002-9610(97)00099-8 DO - 10.1016/S0002-9610(97)00099-8 ID - Jacobi1997 ER - TY - JOUR AU - McCourt, M. AU - Wang, J. H. AU - Sookhai, S. AU - Redmond, H. P. PY - 2000 DA - 2000// TI - Taurolidine inhibits tumor cell growth in vitro and in vivo JO - Ann Surg Oncol VL - 7 UR - https://doi.org/10.1007/s10434-000-0685-6 DO - 10.1007/s10434-000-0685-6 ID - McCourt2000 ER - TY - JOUR AU - Rodak, R. AU - Kubota, H. AU - Ishihara, H. AU - Eugster, H. -. P. AU - Könü, D. AU - Möhler, H. PY - 2005 DA - 2005// TI - Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine JO - J Neurosurg VL - 102 UR - https://doi.org/10.3171/jns.2005.102.6.1055 DO - 10.3171/jns.2005.102.6.1055 ID - Rodak2005 ER - TY - JOUR AU - Sun, B. S. AU - Wang, J. H. AU - Liu, L. L. AU - Gong, S. L. AU - Redmond, H. P. PY - 2007 DA - 2007// TI - Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins JO - J Surg Oncol VL - 96 UR - https://doi.org/10.1002/jso.20827 DO - 10.1002/jso.20827 ID - Sun2007 ER - TY - JOUR AU - Aceto, N. AU - Bertino, P. AU - Barbone, D. AU - Tassi, G. AU - Manzo, L. AU - Porta, C. PY - 2009 DA - 2009// TI - Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma JO - Eur Respir J VL - 34 UR - https://doi.org/10.1183/09031936.00102308 DO - 10.1183/09031936.00102308 ID - Aceto2009 ER - TY - JOUR AU - Chromik, A. M. AU - Daigeler, A. AU - Bulut, D. AU - Flier, A. AU - May, C. AU - Harati, K. PY - 2010 DA - 2010// TI - Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines JO - J Exp Clin Cancer Res VL - 29 UR - https://doi.org/10.1186/1756-9966-29-21 DO - 10.1186/1756-9966-29-21 ID - Chromik2010 ER - TY - STD TI - Stendel R, Picht T, Schilling A, Heidenreich J, Loddenkemper C, Jänisch W, et al. Treatment of glioblastoma with intravenous taurolidine. First clinical experience. Anticancer Res. 2004;24:1143–7. ID - ref16 ER - TY - JOUR AU - Braumann, C. AU - Gutt, C. N. AU - Scheele, J. AU - Menenakos, C. AU - Willems, W. AU - Mueller, J. M. PY - 2009 DA - 2009// TI - Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial JO - World J Surg Oncol VL - 7 UR - https://doi.org/10.1186/1477-7819-7-32 DO - 10.1186/1477-7819-7-32 ID - Braumann2009 ER - TY - JOUR AU - Gong, L. AU - Greenberg, H. E. AU - Perhach, J. L. AU - Waldman, S. A. AU - Kraft, W. K. PY - 2007 DA - 2007// TI - The pharmacokinetics of taurolidine metabolites in healthy volunteers JO - J Clin Pharmacol VL - 47 UR - https://doi.org/10.1177/0091270007299929 DO - 10.1177/0091270007299929 ID - Gong2007 ER - TY - JOUR AU - Clauss, K. AU - Lück, E. AU - Rymon Lipinski, G. W. PY - 1976 DA - 1976// TI - Acetosulfam, a new sweetener. 1. Synthesis and properties (author’s transl) JO - Zeitschrift für Leb und -forsch VL - 162 UR - https://doi.org/10.1007/BF01104359 DO - 10.1007/BF01104359 ID - Clauss1976 ER - TY - JOUR AU - Jacobi, C. A. AU - Sabat, R. AU - Ordemann, J. AU - Wenger, F. AU - Volk, H. D. AU - Müller, J. M. PY - 1997 DA - 1997// TI - Peritoneal instillation of taurolidine and heparin for preventing intraperitoneal tumor growth and trocar metastases in laparoscopic operations in the rat model JO - Langenbecks Arch für Chir VL - 382 UR - https://doi.org/10.1007/PL00014641 DO - 10.1007/PL00014641 ID - Jacobi1997 ER - TY - JOUR AU - Jacobi, C. A. AU - Peter, F. J. AU - Wenger, F. A. AU - Ordemann, J. AU - Müller, J. M. PY - 1999 DA - 1999// TI - New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat JO - Dig Surg VL - 16 UR - https://doi.org/10.1159/000018754 DO - 10.1159/000018754 ID - Jacobi1999 ER - TY - JOUR AU - Stendel, R. AU - Scheurer, L. AU - Schlatterer, K. AU - Stalder, U. AU - Pfirrmann, R. W. AU - Fiss, I. PY - 2007 DA - 2007// TI - Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients JO - Clin Pharmacokinet VL - 46 UR - https://doi.org/10.2165/00003088-200746060-00005 DO - 10.2165/00003088-200746060-00005 ID - Stendel2007 ER - TY - JOUR AU - Gorman, S. P. AU - McCafferty, D. F. AU - Woolfson, A. D. AU - Jones, D. S. PY - 1987 DA - 1987// TI - Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent JO - J Appl Bacteriol VL - 62 UR - https://doi.org/10.1111/j.1365-2672.1987.tb04926.x DO - 10.1111/j.1365-2672.1987.tb04926.x ID - Gorman1987 ER - TY - JOUR AU - Bedrosian, I. AU - Sofia, R. D. AU - Wolff, S. M. AU - Dinarello, C. A. PY - 1991 DA - 1991// TI - Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells JO - Cytokine VL - 3 UR - https://doi.org/10.1016/1043-4666(91)90483-T DO - 10.1016/1043-4666(91)90483-T ID - Bedrosian1991 ER - TY - STD TI - Leithäuser ML, Rob PM, Sack K. Pentoxifylline, cyclosporine a and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-alpha production in rat mesangial cell cultures. Exp Nephrol. 1997;5:100–4. ID - ref25 ER - TY - JOUR AU - Stendel, R. AU - Biefer, H. R. C. AU - Dékány, G. M. AU - Kubota, H. AU - Münz, C. AU - Wang, S. PY - 2009 DA - 2009// TI - The antibacterial substance taurolidine exhibits anti-neoplastic action based on a mixed type of programmed cell death JO - Autophagy VL - 5 UR - https://doi.org/10.4161/auto.5.2.7404 DO - 10.4161/auto.5.2.7404 ID - Stendel2009 ER - TY - JOUR AU - Vanden Berghe, T. AU - Vanlangenakker, N. AU - Parthoens, E. AU - Deckers, W. AU - Devos, M. AU - Festjens, N. PY - 2010 DA - 2010// TI - Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features JO - Cell Death Differ VL - 17 UR - https://doi.org/10.1038/cdd.2009.184 DO - 10.1038/cdd.2009.184 ID - Vanden Berghe2010 ER - TY - JOUR AU - Ouyang, L. AU - Shi, Z. AU - Zhao, S. AU - Wang, F. -. T. AU - Zhou, T. -. T. AU - Liu, B. PY - 2012 DA - 2012// TI - Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis JO - Cell Prolif VL - 45 UR - https://doi.org/10.1111/j.1365-2184.2012.00845.x DO - 10.1111/j.1365-2184.2012.00845.x ID - Ouyang2012 ER - TY - STD TI - Stendel R, Scheurer L, Stoltenburg-Didinger G, Brock M, Möhler H. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine. Anticancer Res. 2003;23:2309–14. ID - ref29 ER - TY - JOUR AU - Shrayer, D. P. AU - Lukoff, H. AU - King, T. AU - Calabresi, P. PY - 2003 DA - 2003// TI - The effect of Taurolidine on adherent and floating subpopulations of melanoma cells JO - Anti-Cancer Drugs VL - 14 UR - https://doi.org/10.1097/00001813-200304000-00007 DO - 10.1097/00001813-200304000-00007 ID - Shrayer2003 ER - TY - JOUR AU - Nici, L. AU - Monfils, B. AU - Calabresi, P. PY - 2004 DA - 2004// TI - The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-0196-03 DO - 10.1158/1078-0432.CCR-0196-03 ID - Nici2004 ER - TY - JOUR AU - Möhler, H. AU - Pfirrmann, R. W. AU - Frei, K. PY - 2014 DA - 2014// TI - Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents JO - Int J Oncol VL - 45 ID - Möhler2014 ER - TY - JOUR AU - Opitz, I. AU - Sigrist, B. AU - Hillinger, S. AU - Lardinois, D. AU - Stahel, R. AU - Weder, W. PY - 2007 DA - 2007// TI - Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma JO - Lung Cancer VL - 56 UR - https://doi.org/10.1016/j.lungcan.2007.01.024 DO - 10.1016/j.lungcan.2007.01.024 ID - Opitz2007 ER - TY - JOUR AU - Tait, S. W. G. AU - Ichim, G. AU - Green, D. R. PY - 2014 DA - 2014// TI - Die another way--non-apoptotic mechanisms of cell death JO - J Cell Sci VL - 127 UR - https://doi.org/10.1242/jcs.093575 DO - 10.1242/jcs.093575 ID - Tait2014 ER - TY - JOUR AU - Kroemer, G. AU - Martin, S. J. PY - 2005 DA - 2005// TI - Caspase-independent cell death JO - Nat Med VL - 11 UR - https://doi.org/10.1038/nm1263 DO - 10.1038/nm1263 ID - Kroemer2005 ER - TY - JOUR AU - Kim, E. -. A. AU - Jang, J. -. H. AU - Lee, Y. -. H. AU - Sung, E. -. G. AU - Song, I. -. H. AU - Kim, J. -. Y. PY - 2014 DA - 2014// TI - Dioscin induces caspase-independent apoptosis through activation of apoptosis-inducing factor in breast cancer cells JO - Apoptosis VL - 19 UR - https://doi.org/10.1007/s10495-014-0994-z DO - 10.1007/s10495-014-0994-z ID - Kim2014 ER - TY - JOUR AU - Leon, L. J. AU - Pasupuleti, N. AU - Gorin, F. AU - Carraway, K. L. PY - 2013 DA - 2013// TI - A cell-permeant amiloride derivative induces caspase-independent JO - AIF-mediated programmed necrotic death of breast cancer cells PLoS One VL - 8 ID - Leon2013 ER - TY - JOUR AU - Braumann, C. AU - Ordemann, J. AU - Kilian, M. AU - Wenger, F. A. AU - Jacobi, C. A. PY - 2003 DA - 2003// TI - Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy JO - Clin. Exp. Metastasis. VL - 20 UR - https://doi.org/10.1023/A:1025402919341 DO - 10.1023/A:1025402919341 ID - Braumann2003 ER - TY - JOUR AU - Opitz, I. AU - Veen, H. C. AU - Braumann, C. AU - Ablassmaier, B. AU - Führer, K. AU - Jacobi, C. A. PY - 2003 DA - 2003// TI - The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model JO - Surg Endosc VL - 17 UR - https://doi.org/10.1007/s00464-002-9161-7 DO - 10.1007/s00464-002-9161-7 ID - Opitz2003 ER - TY - JOUR AU - Bobrich, E. AU - Braumann, C. AU - Opitz, I. AU - Menenakos, C. AU - Kristiansen, G. AU - Jacobi, C. A. PY - 2007 DA - 2007// TI - Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy JO - J Surg Res VL - 137 UR - https://doi.org/10.1016/j.jss.2006.07.013 DO - 10.1016/j.jss.2006.07.013 ID - Bobrich2007 ER - TY - JOUR AU - Braumann, C. AU - Stuhldreier, B. AU - Bobrich, E. AU - Menenakos, C. AU - Rogalla, S. AU - Jacobi, C. A. PY - 2005 DA - 2005// TI - High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats JO - J Surg Res VL - 129 UR - https://doi.org/10.1016/j.jss.2005.03.012 DO - 10.1016/j.jss.2005.03.012 ID - Braumann2005 ER - TY - JOUR AU - Nestler, G. AU - Schulz, H. U. AU - Schubert, D. AU - Krüger, S. AU - Lippert, H. AU - Pross, M. PY - 2005 DA - 2005// TI - Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats JO - Surg Endosc VL - 19 UR - https://doi.org/10.1007/s00464-003-9301-8 DO - 10.1007/s00464-003-9301-8 ID - Nestler2005 ER - TY - JOUR AU - Raue, W. AU - Kilian, M. AU - Braumann, C. AU - Atanassow, V. AU - Makareinis, A. AU - Caldenas, S. PY - 2010 DA - 2010// TI - Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model JO - Int J Color Dis VL - 25 UR - https://doi.org/10.1007/s00384-009-0819-7 DO - 10.1007/s00384-009-0819-7 ID - Raue2010 ER - TY - JOUR AU - Kilian, M. AU - Mautsch, I. AU - Braumann, C. AU - Schimke, I. AU - Guski, H. AU - Jacobi, C. A. PY - 2003 DA - 2003// TI - Effects of taurolidine and octreotide on tumor growth and lipid peroxidation after staging-laparoscopy in ductal pancreatic cancer JO - Prostaglandins Leukot Essent Fatty Acids VL - 69 UR - https://doi.org/10.1016/S0952-3278(03)00108-X DO - 10.1016/S0952-3278(03)00108-X ID - Kilian2003 ER - TY - JOUR AU - Braumann, C. AU - Jacobi, C. A. AU - Rogalla, S. AU - Menenakos, C. AU - Fuehrer, K. AU - Trefzer, U. PY - 2007 DA - 2007// TI - The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model JO - J Surg Res VL - 143 UR - https://doi.org/10.1016/j.jss.2007.01.041 DO - 10.1016/j.jss.2007.01.041 ID - Braumann2007 ER - TY - JOUR AU - Braumann, C. AU - Ordemann, J. AU - Wildbrett, P. AU - Jacobi, C. A. PY - 2000 DA - 2000// TI - Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats JO - Clin Exp Metastasis VL - 18 UR - https://doi.org/10.1023/A:1011988923523 DO - 10.1023/A:1011988923523 ID - Braumann2000 ER - TY - JOUR AU - Da Costa, M. L. AU - Redmond, H. P. AU - Bouchier-Hayes, D. J. PY - 2001 DA - 2001// TI - Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery JO - J Surg Res VL - 101 UR - https://doi.org/10.1006/jsre.2001.6250 DO - 10.1006/jsre.2001.6250 ID - Da Costa2001 ER - TY - JOUR AU - Darnowski, J. W. AU - Goulette, F. A. AU - Cousens, L. P. AU - Chatterjee, D. AU - Calabresi, P. PY - 2004 DA - 2004// TI - Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer JO - Cancer Chemother Pharmacol VL - 54 UR - https://doi.org/10.1007/s00280-004-0806-1 DO - 10.1007/s00280-004-0806-1 ID - Darnowski2004 ER -